Media coverage
1
Media coverage
Title BRISTOL MYERS SQUIBB : U.S. FDA Approves Expanded Use of Bristol-Myers Squibb’s Daklinza (daclatasvir) for Additional Challenging-to-treat Patients with Genotype 1 or Genotype 3 Chronic Hepatitis C Media name/outlet 4 Traders Country United States Date 2/5/16 Persons Fred Poordad